Taipei Medical University

Medicine & Life Sciences

1. Taiwan 100%
2. Neoplasms 32%
3. Population 25%
4. Meta-Analysis 21%
5. Therapeutics 21%
6. Cohort Studies 20%
7. Apoptosis 19%
8. Confidence Intervals 18%
9. Stroke 17%
10. Proteins 16%
11. Systematic Reviews 14%
12. Genes 14%
13. Breast Neoplasms 14%
14. Odds Ratio 12%
15. Randomized Controlled Trials 12%
16. In Vitro Techniques 12%
17. Mortality 12%
18. Neoplasm Metastasis 12%
19. Wounds and Injuries 12%
20. Hepatocellular Carcinoma 12%
21. Colorectal Neoplasms 12%
22. Databases 12%
23. Growth 11%
24. Inflammation 10%
25. Lung 10%
26. Serum 10%
27. Survival 10%
28. Lung Neoplasms 10%
29. Pharmaceutical Preparations 10%
30. National Health Programs 9%
31. Incidence 9%
32. Reactive Oxygen Species 9%
33. Down-Regulation 9%
34. Kidney 9%
35. Autophagy 9%
36. Health 9%
37. Lipopolysaccharides 9%
38. Exercise 8%
39. Brain 8%
40. Oxidative Stress 8%
41. Liver 8%
42. Chronic Renal Insufficiency 8%
43. Antioxidants 8%
44. Biomarkers 8%
45. Depression 8%
46. Prostatic Neoplasms 8%
47. Arsenic 8%
48. Gene Expression 8%
49. Child 8%
50. Phosphorylation 8%
51. Elderly 8%
52. Macrophages 7%
53. Glucose 7%
54. Sleep 7%
55. MicroRNAs 7%
56. Endothelial Cells 7%
57. Up-Regulation 7%
58. Quality of Life 7%
59. Mouth Neoplasms 7%
60. Nitric Oxide 7%
61. Cell Line 7%
62. Anti-Inflammatory Agents 7%
63. Cytokines 7%
64. Control Groups 7%
65. Logistic Models 7%
66. Blood Platelets 7%
67. Non-Small Cell Lung Carcinoma 7%
68. Messenger RNA 7%
69. Cell Proliferation 7%
70. Nanoparticles 6%
71. Bone and Bones 6%
72. Type 2 Diabetes Mellitus 6%
73. Retrospective Studies 6%
74. Atrial Fibrillation 6%
75. Carcinoma 6%
76. Nurses 6%
77. Renal Dialysis 6%
78. Recurrence 6%
79. Pain 6%
80. Cross-Sectional Studies 6%
81. Glioblastoma 6%
82. Cell Movement 6%
83. Mesenchymal Stem Cells 6%
84. Case-Control Studies 6%
85. Drug Therapy 6%
86. Adenocarcinoma of Lung 6%
87. ErbB Receptors 6%
88. Hypertension 6%
89. Dementia 6%
90. Fibroblasts 6%
91. Squamous Cell Carcinoma 6%
92. Delivery of Health Care 6%
93. Schizophrenia 5%
94. Infections 5%
95. Metabolic Syndrome 5%
96. Carcinogenesis 5%
97. Bipolar Disorder 5%
98. Safety 5%
99. Obesity 5%
100. Traumatic Brain Injury 5%